Cargando…
Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study
SIMPLE SUMMARY: Over 95% of cervical cancers are caused by the human papilloma virus (HPV). Locally advanced HPV-related cancers release tiny bits of tumour containing HPV-DNA into the blood (cHPV-DNA). The presence of cHPV-DNA in the blood can serve as a potential marker of cancer and should be abs...
Autores principales: | Bryan, Stacey J., Lee, Jen, Gunu, Richard, Jones, Allison, Olaitan, Adeola, Rosenthal, Adam N., Cutts, Ros J., Garcia-Murillas, Isaac, Turner, Nick, Lalondrelle, Susan, Bhide, Shreerang A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177194/ https://www.ncbi.nlm.nih.gov/pubmed/37174056 http://dx.doi.org/10.3390/cancers15092590 |
Ejemplares similares
-
Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer
por: Lalondrelle, Susan, et al.
Publicado: (2023) -
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
por: Lee, Jen Y., et al.
Publicado: (2020) -
Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
por: Lee, Jen Y, et al.
Publicado: (2017) -
HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review
por: Bryan, Stacey, et al.
Publicado: (2019) -
Updates on HPV Vaccination
por: Illah, Ojone, et al.
Publicado: (2023)